The global infant formula market is expanding rapidly, driven by rising disposable incomes in Asia-Pacific, premiumisation of products, and growth in specialised and follow-on formulas. According to the data you provided, the market grew from about US$82.4 billion (2024) to US$90.27 billion (2025) and is projected to reach ~US$207.19 billion by 2034, implying a strong mid- to long-term CAGR and sizable category shifts toward premium, baby-food extensions and modern retail distribution. Asia-Pacific led the market in 2024, supermarkets & hypermarkets were the largest distribution channel, while follow-on milk and specialty baby-food segments are among the fastest growing.
Download the free sample and get the full report for complete insights and forecasts on this market @ https://www.towardshealthcare.com/download-sample/5564
Top leading companies
1) Nestlé (Infant & Early Life Nutrition: NAN, Illuma, Gerber)
◉Quick facts: Global leader in infant & toddler nutrition with major brands such as NAN, Illuma, Nestogen and a large baby-food portfolio under Gerber (Nestlé nutrition division is a major pillar of the company).
◉Strengths:
•Very large global manufacturing & distribution footprint (strong presence across APAC, Europe, Americas).
•Investment in premiumisation and R&D (focus on HMOs, advanced formulations and targeted nutrition for different life stages).
•Wide portfolio spanning value to premium segments — helps capture both mass and affluent consumers.
◉Key products / brands: NAN, Illuma (premium), Nestogen, Gerber baby foods, plus fortified/medical nutrition SKUs.
2) Danone (Specialized Nutrition: Aptamil / Nutricia / Bledina)
◉Quick facts: Danone’s Specialized Nutrition arm (including Aptamil, Nutricia) is a top global player in infant formula and baby foods, with especially strong positions in Europe and growing activity in APAC and the U.S. market via exports.
◉Strengths:
•Scientific/medical-nutrition positioning — strong clinical credentials and R&D pipeline for infant formulations.
•Flexible supply chain — Danone has used European production to ship into other regions during supply shortfalls.
•Strong brand equity in Europe (Aptamil/Nutricia) and established baby-food portfolio.
◉Key products / brands: Aptamil, Nutrilon/Nutricia, Bledina (baby food), stage-based formula ranges and specialty medical nutrition lines.
3) Abbott Laboratories (Nutrition: Similac)
◉Quick facts: Abbott’s Nutrition division sells Similac (flagship infant formula) and a portfolio of specialty and clinical infant feeds; it is a major player in the U.S. and other markets.
◉Strengths:
•Strong clinical/product development capabilities (focus on close-to-breast-milk formulations, HMOs, prebiotics/probiotics).
•Broad product range including standard, specialty, metabolic and high-calorie formulas used in hospitals and by paediatricians.
•Solid regulatory and quality focus with global distribution in retail and healthcare channels.
◉Key products / brands: Similac family (Similac 360 Total Care, Similac with Iron 24, specialty formulas), plus clinical nutrition SKUs for hospitals.
4) Reckitt (Mead Johnson — Enfamil / Nutramigen)
◉Quick facts: Reckitt owns Mead Johnson’s portfolio (including Enfamil, historically one of the top global infant-formula brands). The business has faced litigation and strategic review in recent years; company is evaluating options for the nutrition unit.
◉Strengths:
•Very strong brand recognition for Enfamil (noted as a top recommended brand among U.S. paediatricians) and established specialty allergy products (Nutramigen).
•Deep clinical relationships with healthcare professionals and hospital channels for specialized nutrition.
•Commercial / strategic context (latest):
Reckitt has been conducting a strategic review of Mead Johnson and has signalled possible divestment options while defending product safety amid litigation; this is an active corporate development area that may affect the business’s future structure.
◉Key products / brands: Enfamil, Nutramigen, plus specialized pediatric nutrition products.
5) Royal FrieslandCampina (Friso, Friso Gold, ingredients business)
◉Quick facts: FrieslandCampina is a major dairy cooperative with Friso / Friso Gold infant-nutrition brands and an ingredients business supplying MFGM, oligosaccharides and other components used by formulators.
◉Strengths:
•Strong dairy sourcing (cooperative model) and ingredient-level capabilities (supplies MFGM, lactoferrin and other speciality ingredients to formulators).
•Regional leadership in parts of Asia (Friso is a recognized premium brand in many APAC markets).
•Continued investment in ingredient approvals and country registrations (supports faster product launches).
◉Key products / brands: Friso / Friso Gold (stage-based formulas), ingredient lines (Vivinal® MFGM, proteins, etc.).
Immediate Delivery Available | Buy This Premium Research @ https://www.towardshealthcare.com/price/5564
Access our exclusive, data-rich dashboard dedicated to the therapeutic area sector – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About the Author
